Top Buy
Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
---|---|---|---|---|---|---|---|
Eli Lilly Corp. | 50 | 0 | 5 | 0 | 710,30 € | 771,54 € | 8,62 % |
Biogen Inc. | 46 | 1 | 7 | 1 | 211,70 € | 294,45 € | 39,09 % |
Vertex Pharmaceuticals Inc. | 45 | 2 | 6 | 0 | 405,60 € | 408,36 € | 0,68 % |
Regeneron Pharmaceuticals Inc. | 36 | 1 | 5 | 0 | 890,60 € | 958,32 € | 7,60 % |
Johnson & Johnson | 32 | 1 | 3 | 0 | 141,98 € | 196,36 € | 38,30 % |
Neurocrine Bioscience | 29 | 0 | 8 | 0 | 130,65 € | 140,60 € | 7,62 % |
Merck & Co. Inc. | 28 | 1 | 1 | 0 | 120,60 € | 124,93 € | 3,59 % |
Pfizer Inc. | 30 | 4 | 2 | 0 | 26,62 € | 40,66 € | 52,74 % |
Cytokinetics Inc. | 27 | 1 | 4 | 0 | 55,50 € | 85,64 € | 54,31 % |
Amgen Inc. | 25 | 0 | 5 | 0 | 289,65 € | 298,90 € | 3,19 % |
Intra-Cellular Therapies Inc. | 24 | 0 | 7 | 0 | 61,50 € | 79,55 € | 29,36 % |
Jazz Pharmaceuticals plc | 23 | 0 | 3 | 0 | 101,70 € | 184,92 € | 81,83 % |
Zoetis Inc. A | 23 | 1 | 5 | 0 | 159,92 € | 200,06 € | 25,10 % |
Trinity Biotech ADR | 22 | 0 | 0 | 0 | 0,41 € | - | - |